Insulin glargine and lixisenatide Subcutaneous and Noxafil (Posaconazole Delayed-Release Tablets)
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Noxafil (Posaconazole Delayed-Release Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Noxafil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Noxafil (Posaconazole Injection)
- Insulin glargine and lixisenatide Subcutaneous-Noxafil (Posaconazole Oral Suspension)
- Insulin glargine and lixisenatide Subcutaneous-Noxafil Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Noxifol-D
- Insulin glargine and lixisenatide Subcutaneous-Noxivent
- Insulin glargine and lixisenatide Subcutaneous-NP Thyroid
- Noxafil (Posaconazole Delayed-Release Tablets)-Insulin glargine, recombinant Subcutaneous
- Noxafil (Posaconazole Delayed-Release Tablets)-Insulin glulisine
- Noxafil (Posaconazole Delayed-Release Tablets)-Insulin Glulisine (Cartridges and Pens)
- Noxafil (Posaconazole Delayed-Release Tablets)-Insulin Glulisine (Vials)
- Noxafil (Posaconazole Delayed-Release Tablets)-Insulin glulisine Subcutaneous
- Noxafil (Posaconazole Delayed-Release Tablets)-Insulin human inhaled Inhalation